4J. E. Bennett,J. C. Wakefield. A comparison of a bayesian population method with two methods as implemented in commercially available software[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(4):403～432
5Pascal Girard,Lewis B. Sheiner,Helen Kastrissios,Terrence F. Blaschke. Do we need full compliance data for population pharmacokinetic analysis?[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(3):265～282
6René Bruno,Nicole Vivier,Jean Claude Vergniol,Susan L. Phillips,Guy Montay,Lewis B. Sheiner. A population pharmacokinetic model for docetaxel (Taxotere?): Model building and validation[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(2):153～172
7E. Niclas Jonsson,Janet R. Wade,Mats O. Karlsson. Comparison of some practical sampling strategies for population pharmacokinetic studies[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(2):245～263
8Nicola G. Best,Keith K. C. Tan,Wally R. Gilks,David J. Spiegelhalter. Estimation of population pharmacokinetics using the Gibbs sampler[J] 1995,Journal of Pharmacokinetics and Biopharmaceutics(4):407～435
9Janet R. Wade,Stuart L. Beal,Nancy C. Sambol. Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis[J] 1994,Journal of Pharmacokinetics and Biopharmaceutics(2):165～177
10M. O. Karlsson,L. B. Sheiner. The importance of modeling interoccasion variability in population pharmacokinetic analyses[J] 1993,Journal of Pharmacokinetics and Biopharmaceutics(6):735～750
二级参考文献2
1曾衍霖.临床药代动力学中群体及个体参数的估算[J]中国临床药理学杂志,1986(01).
2S. Vozeh,G. Katz,V. Steiner,F. Follath. Population pharmacokinetic parameters in patients treated with oral mexiletine[J] 1982,European Journal of Clinical Pharmacology(5):445～451
